Publication:
HCV spontaneous clearers showed low senescence profile in people living with HIV under long ART

dc.contributor.authorLara-Aguilar, Violeta
dc.contributor.authorCrespo-Bermejo, Celia
dc.contributor.authorLlamas-Adán, Manuel
dc.contributor.authorGrande-García, Sergio
dc.contributor.authorCortijo-Alfonso, María Engracia
dc.contributor.authorMartín-Carbonero, Luz
dc.contributor.authorDomínguez, Lourdes
dc.contributor.authorRyan, Pablo
dc.contributor.authorde Los Santos, Ignacio
dc.contributor.authorBartolomé-Sánchez, Sofía
dc.contributor.authorValle-Millares, Daniel
dc.contributor.authorJimenez-Sousa, Maria Angeles
dc.contributor.authorBriz, Veronica
dc.contributor.authorFernandez-Rodriguez, Amanda
dc.contributor.authorMultidisciplinary HIV/Hepatitis Viral Coinfection Group (COVIHEP)
dc.contributor.funderMinisterio de Ciencia e Innovación (España)
dc.contributor.funderInstituto de Salud Carlos III
dc.contributor.funderUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF)
dc.contributor.funderFundación Universidad Alfonso X el Sabio
dc.contributor.funderFundación Banco Santander
dc.contributor.funderCentro de Investigación Biomédica en Red - CIBERINFEC (Enfermedades Infecciosas)
dc.contributor.funderAgencia Estatal de Investigación (España)
dc.date.accessioned2023-08-24T09:00:45Z
dc.date.available2023-08-24T09:00:45Z
dc.date.issued2023-07
dc.description.abstractCoinfection with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) increases immune activation, inflammation, and oxidative stress that could lead to premature senescence. Different HCV infections, either acute or chronic infection, could lead to distinct premature cellular senescence in people living with HIV (PLWHIV). Observational study in 116 PLWHIV under antiretroviral treatment with different HCV status: (i) n = 45 chronically infected with HCV (CHC); (ii) n = 36 individuals who spontaneously clarify HCV (SC); (iii) n = 35 HIV controls. Oxidative stress biomarkers were analyzed at lipid, DNA, protein, and nitrates levels, as well as antioxidant capacity and glutathione reductase enzyme. Replicative senescence was evaluated by relative telomere length (RTL) measurement. Additionally, 26 markers of Senescence-Associated Secretory Phenotype (SASP) were analyzed by multiplex immunoassays (Luminex xMAP technology). Differences were evaluated by generalized linear model (GLMs) adjusted by most significant covariates. The SC group had a senescence signature similar to the HIV control group and slightly lower SASP levels. However, significant differences were observed with respect to the CHC group, where an increase in the nitrate concentration [adjusted arithmetic mean ratio, aAMR = 1.73 (1.27-2.35), p < 0.001, q = 0.009] and the secretion of 13 SASP-associated factors [granulocyte macrophage colony-stimulating factor (GM-CSF), interferon-β, interleukin (IL)-1β, IL-2, IL-8, IL-13, tumor necrosis factor (TNF)-α, IL-1α, IL-1RA, IL-7, IL-15, C-X-C motif chemokine ligand 10 (IP-10), stem cell factor (SCF); q < 0.1)] was detected. The CHC group also showed higher values of IL-1α, IP-10, and placental growth factor 1 (PIGF-1) than HIV controls. The SC group showed a slightly lower senescence profile than the HIV group, which could indicate a more efficient control of viral-induced senescence due to their immune strengths. Chronic HCV infection in PLWHIV led to an increase in nitrate and elevated SASP biomarkers favoring the establishment of viral persistence.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipThis study was supported by grants from Ministerio de Ciencia e Innovación (grant number PID2021‐126781OB‐I00 to A. F. R. and V. B.) funded by MCIN/AEI/10.13039/501100011033 by “ERDF A way of making Europe,” Instituto de Salud Carlos III (PI15CIII/00031 and PI18CIII/00020 to V. B. and A. F. R.), Fundación Universidad Alfonso X el Sabio (FUAX)—Santander (grant number 1.010.932 to A. F. R.). The study was also supported by the Centro de Investigación Biomédica en Red (CIBER) en Enfermedades Infecciosas (CB21/13/00044 and CB21/13/00107).es_ES
dc.format.number7es_ES
dc.format.pagee28955es_ES
dc.format.volume95es_ES
dc.identifier.citationJ Med Virol. 2023 Jul;95(7):e28955.es_ES
dc.identifier.doi10.1002/jmv.28955es_ES
dc.identifier.e-issn1096-9071es_ES
dc.identifier.journalJournal of medical virologyes_ES
dc.identifier.pubmedID37465865es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/16335
dc.language.isoenges_ES
dc.publisherWiley
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PID2021‐126781OB‐I00es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/PI15CIII/00031es_ES
dc.relation.projectFISinfo:fis/Instituto de Salud Carlos III/Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia/Subprograma Estatal de Generación de Conocimiento/PI18-ISCIII Modalidad Proyectos de Investigacion en Salud Intramurales. (2018)/PI18CIII/00020es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/CB21/13/00044es_ES
dc.relation.projectFISinfo:eu-repo/grantAgreement/ES/CB21/13/00107es_ES
dc.relation.publisherversionhttps://doi.org/10.1002/jmv.28955es_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectHCV/HIVes_ES
dc.subjectSASPes_ES
dc.subjectOxidative stresses_ES
dc.subjectSenescencees_ES
dc.subjectSpontaneous clearancees_ES
dc.subjectTelomerees_ES
dc.subject.meshHIV Infectionses_ES
dc.subject.meshHepatitis Ces_ES
dc.subject.meshCoinfectiones_ES
dc.subject.meshHumanses_ES
dc.subject.meshFemalees_ES
dc.subject.meshHIVes_ES
dc.subject.meshHepaciviruses_ES
dc.subject.meshChemokine CXCL10es_ES
dc.subject.meshNitrateses_ES
dc.subject.meshPlacenta Growth Factores_ES
dc.subject.meshBiomarkerses_ES
dc.subject.meshTumor Necrosis Factor-alphaes_ES
dc.titleHCV spontaneous clearers showed low senescence profile in people living with HIV under long ARTes_ES
dc.typeresearch articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublicationf30344f7-c914-4c52-b7aa-ccb62d80d362
relation.isAuthorOfPublication8c0c9d1f-fa42-4d34-9fb5-cef4d853b4df
relation.isAuthorOfPublication667c36f3-fc12-4350-8c65-412f420687f0
relation.isAuthorOfPublication6ad4e05e-55ee-4f75-8e79-5e874efe2011
relation.isAuthorOfPublicationfe001308-aea7-4f72-8de4-6f216e8bbc53
relation.isAuthorOfPublication1491748a-f604-496c-8e06-447e866a97e6
relation.isAuthorOfPublication7dfa2699-8d26-42af-a510-b0ef10e0b9cc
relation.isAuthorOfPublication2bf7faec-7f00-44ba-9494-efb396305551
relation.isAuthorOfPublication727b9535-a250-4e80-969f-c5d33f92246d
relation.isAuthorOfPublication6a32a4a3-2d81-43c5-8295-48346efbf498
relation.isAuthorOfPublication.latestForDiscoveryf30344f7-c914-4c52-b7aa-ccb62d80d362
relation.isFunderOfPublication289dce42-6a28-4892-b0a8-c70c46cbb185
relation.isFunderOfPublication7d739953-4b68-4675-b5bb-387a9ab74b66
relation.isFunderOfPublicationefa64f05-b985-4984-8f1e-5fc4ef21f502
relation.isFunderOfPublicationa6ae0db5-9c7b-4544-b685-008673740ac3
relation.isFunderOfPublication943a5029-a663-403e-84ea-b4cad184a4ca
relation.isFunderOfPublication0b5a6d3a-4d4d-4346-9bcc-9359bbe13e72
relation.isFunderOfPublication54733407-1d78-4c44-bf4c-8c8a7592aa4b
relation.isFunderOfPublication.latestForDiscovery289dce42-6a28-4892-b0a8-c70c46cbb185
relation.isPublisherOfPublicationd81e762a-95f7-4917-88a1-8004b3b8caa7
relation.isPublisherOfPublication.latestForDiscoveryd81e762a-95f7-4917-88a1-8004b3b8caa7

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
HCV_SpontaneousClearersShowed_2023.pdf
Size:
2.16 MB
Format:
Adobe Portable Document Format
Description:
Articulo
Loading...
Thumbnail Image
Name:
Suplementary_HCV_SpontaneousClearersShowed_2023.pdf
Size:
636.1 KB
Format:
Adobe Portable Document Format
Description:
Supplementary material